Louisiana State Employees Retirement System’s Sarepta Therapeutics SRPT Stock Holding History

Louisiana State Employees Retirement System’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$832K	Sell	46,300 -200	-0.4%	-$3.78K	0.01%	1198
2026 Q1	$1.01M	Sell	46,500 -1,500	-3%	-$29K	0.02%	1013
2025 Q4	$1.03M	Buy	48,000 +3,100	+7%	+$65.3K	0.02%	992
2025 Q3	$865K	Buy	44,900 +17,300	+63%	+$308K	0.01%	1087
2025 Q2	$472K	Buy	27,600 +800	+3%	+$34.1K	0.01%	1338
2025 Q1	$1.71M	Buy	26,800 +300	+1%	+$31.6K	0.03%	580
2024 Q4	$3.22M	Buy	26,500 +100	+0.4%	+$12.3K	0.06%	261
2024 Q3	$3.3M	Sell	26,400 -300	-1%	-$41.5K	0.06%	262
2024 Q2	$4.22M	Buy	+26,700	New	+$3.43M	0.08%	175

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Louisiana State Employees Retirement System's SRPT Position: Q2 2026 in Review

Louisiana State Employees Retirement System reduced its Sarepta Therapeutics (SRPT) stake by 0.43% in Q2 2026, selling an estimated $3.78K and leaving 46,300 shares worth $832K. The position accounts for 0.01% of the portfolio, ranked #1198.

Louisiana State Employees Retirement System first reported a position in SRPT in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.22M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Louisiana State Employees Retirement System held 46,300 shares of Sarepta Therapeutics worth $832K as of Q2 2026.
Louisiana State Employees Retirement System sold 200 Sarepta Therapeutics shares in Q2 2026, an estimated $3.78K.
Sarepta Therapeutics made up 0.01% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #1198 holding.
Louisiana State Employees Retirement System first reported a position in Sarepta Therapeutics in Q2 2024 and has held it in 9 quarters since.
Louisiana State Employees Retirement System's Sarepta Therapeutics position peaked at $4.22M in Q2 2024.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.